What drives "fibrinolysis"?

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

The timely removal of blood clots and fibrin deposits is essential in the regulation of haemostasis. This is achieved by the fibrinolytic system, an enzymatic process that regulates the activation of plasminogen into its proteolytic form, plasmin. This is a self-regulated event as the very presence of fibrin initiates plasminogen activation on the fibrin surface due to the presentation of exposed C-terminal lysine residues in fibrin that allow plasminogen to position itself via its lysine binding sites and to be more efficiently cleaved by tissue-type plasminogen activator (t-PA). Hence fibrin, the ultimate substrate of plasmin during fibrinolysis, is indeed an essential cofactor in the cascade. What has now come to light is that the fibrinolytic system is not solely designed to eliminate fibrin. Indeed, it is a broad acting system that processes a variety of proteins, including many in the brain where there is no fibrin. So what drives t-PA-mediated plasminogen activation when fibrin is not available? This review will describe the broadening role of the fibrinolytic system highlighting the importance of fibrin and other key proteins as facilitators during t-PA-mediated plasminogen activation.

Original languageEnglish
Pages (from-to)303-310
Number of pages8
JournalHamostaseologie
Volume35
Issue number4
DOIs
Publication statusPublished - 2015

Keywords

  • Fibrin
  • Fibrinogen
  • Fibrinolysis inhibitors
  • Nervous system
  • Plasminogen
  • Plasminogen activators

Cite this

Medcalf, Robert L. / What drives "fibrinolysis"?. In: Hamostaseologie. 2015 ; Vol. 35, No. 4. pp. 303-310.
@article{9c61550819b54d379b71f02f08cfba56,
title = "What drives {"}fibrinolysis{"}?",
abstract = "The timely removal of blood clots and fibrin deposits is essential in the regulation of haemostasis. This is achieved by the fibrinolytic system, an enzymatic process that regulates the activation of plasminogen into its proteolytic form, plasmin. This is a self-regulated event as the very presence of fibrin initiates plasminogen activation on the fibrin surface due to the presentation of exposed C-terminal lysine residues in fibrin that allow plasminogen to position itself via its lysine binding sites and to be more efficiently cleaved by tissue-type plasminogen activator (t-PA). Hence fibrin, the ultimate substrate of plasmin during fibrinolysis, is indeed an essential cofactor in the cascade. What has now come to light is that the fibrinolytic system is not solely designed to eliminate fibrin. Indeed, it is a broad acting system that processes a variety of proteins, including many in the brain where there is no fibrin. So what drives t-PA-mediated plasminogen activation when fibrin is not available? This review will describe the broadening role of the fibrinolytic system highlighting the importance of fibrin and other key proteins as facilitators during t-PA-mediated plasminogen activation.",
keywords = "Fibrin, Fibrinogen, Fibrinolysis inhibitors, Nervous system, Plasminogen, Plasminogen activators",
author = "Medcalf, {Robert L.}",
year = "2015",
doi = "10.5482/HAMO-14-10-0050",
language = "English",
volume = "35",
pages = "303--310",
journal = "Hamostaseologie",
issn = "0720-9355",
publisher = "Schattauer",
number = "4",

}

What drives "fibrinolysis"? / Medcalf, Robert L.

In: Hamostaseologie, Vol. 35, No. 4, 2015, p. 303-310.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - What drives "fibrinolysis"?

AU - Medcalf, Robert L.

PY - 2015

Y1 - 2015

N2 - The timely removal of blood clots and fibrin deposits is essential in the regulation of haemostasis. This is achieved by the fibrinolytic system, an enzymatic process that regulates the activation of plasminogen into its proteolytic form, plasmin. This is a self-regulated event as the very presence of fibrin initiates plasminogen activation on the fibrin surface due to the presentation of exposed C-terminal lysine residues in fibrin that allow plasminogen to position itself via its lysine binding sites and to be more efficiently cleaved by tissue-type plasminogen activator (t-PA). Hence fibrin, the ultimate substrate of plasmin during fibrinolysis, is indeed an essential cofactor in the cascade. What has now come to light is that the fibrinolytic system is not solely designed to eliminate fibrin. Indeed, it is a broad acting system that processes a variety of proteins, including many in the brain where there is no fibrin. So what drives t-PA-mediated plasminogen activation when fibrin is not available? This review will describe the broadening role of the fibrinolytic system highlighting the importance of fibrin and other key proteins as facilitators during t-PA-mediated plasminogen activation.

AB - The timely removal of blood clots and fibrin deposits is essential in the regulation of haemostasis. This is achieved by the fibrinolytic system, an enzymatic process that regulates the activation of plasminogen into its proteolytic form, plasmin. This is a self-regulated event as the very presence of fibrin initiates plasminogen activation on the fibrin surface due to the presentation of exposed C-terminal lysine residues in fibrin that allow plasminogen to position itself via its lysine binding sites and to be more efficiently cleaved by tissue-type plasminogen activator (t-PA). Hence fibrin, the ultimate substrate of plasmin during fibrinolysis, is indeed an essential cofactor in the cascade. What has now come to light is that the fibrinolytic system is not solely designed to eliminate fibrin. Indeed, it is a broad acting system that processes a variety of proteins, including many in the brain where there is no fibrin. So what drives t-PA-mediated plasminogen activation when fibrin is not available? This review will describe the broadening role of the fibrinolytic system highlighting the importance of fibrin and other key proteins as facilitators during t-PA-mediated plasminogen activation.

KW - Fibrin

KW - Fibrinogen

KW - Fibrinolysis inhibitors

KW - Nervous system

KW - Plasminogen

KW - Plasminogen activators

UR - http://www.scopus.com/inward/record.url?scp=84964774515&partnerID=8YFLogxK

U2 - 10.5482/HAMO-14-10-0050

DO - 10.5482/HAMO-14-10-0050

M3 - Review Article

VL - 35

SP - 303

EP - 310

JO - Hamostaseologie

JF - Hamostaseologie

SN - 0720-9355

IS - 4

ER -